Why Peptide Therapy Billing Codes Matter for PE-Backed Healthcare Groups
Private equity firms investing in healthcare need every revenue stream to perform at its best. Peptide therapy is one of the fastest-growing areas in medicine, but billing it correctly is a real challenge.
When billing codes are wrong, claims get denied. Denied claims mean lost revenue and slower growth for your PE-backed practice.
Mary Pat Whaley, Founder, Manage My Practice: "The complexity of coding for novel therapeutics like peptides means that practices must invest in specialized billing staff or face persistent revenue leakage through underpayments and denials"
The Basics of Peptide Therapy Billing
Peptide therapy uses small proteins to help the body heal, grow, or fight disease. These treatments are used for things like weight loss, anti-aging, immune support, and tissue repair.
Each peptide treatment needs the right billing code to get paid by insurance. If you use the wrong code, the claim will be rejected or underpaid.
The global peptide therapeutics market is expected to exceed $90 billion by 2028, making accurate billing more important than ever for healthcare groups looking to capture this growth.
Claims using unclassified HCPCS codes like J3490 are denied at rates up to 30% higher than claims using specific drug codes, according to revenue cycle analysts tracking specialty pharmacy billing.
Key CPT Codes for Peptide Therapy
CPT codes are the numbers used to tell insurance companies what service was provided. For peptide therapy, several CPT code categories come into play.
Injection codes like 96372 (therapeutic, prophylactic, or diagnostic injection) are commonly used for peptide administration. Infusion codes such as 96365 through 96368 apply when peptides are delivered through an IV.
Drug Administration Codes
Drug administration codes describe how the peptide was given to the patient. These codes cover injections, infusions, and other methods of delivery.
Code 96401 is used for chemotherapy administration, which sometimes applies to certain peptide treatments. Code 96372 covers subcutaneous or intramuscular injections, which is the most common way peptides are given.
HCPCS Codes for Peptide Products
HCPCS codes identify the specific drug or product used during treatment. These codes start with the letter J and are followed by four numbers.
Many peptide products use unclassified drug codes like J3490 or J3590. As peptide therapies become more common, more specific HCPCS codes are being created for individual products.
Using unclassified codes like J3490 requires detailed documentation and sometimes a letter of medical necessity to avoid claim denials. PE-backed groups should build standard operating procedures around these codes.
Evaluation and Management Codes
E/M codes cover the office visit where the doctor evaluates the patient and decides on treatment. These codes range from 99202 to 99215 for outpatient visits.
Choosing the right E/M level is critical for peptide therapy visits. The visit must be documented to support the level of complexity billed.
Modifier Codes That Impact Reimbursement
Modifiers are two-character codes added to the main CPT code to give more detail. They tell the payer about special circumstances around the service.
Modifier 25 is often used when a significant E/M service happens on the same day as a procedure. Modifier 59 shows that two procedures were distinct and separate services.
Common Billing Mistakes PE Healthcare Groups Make
One of the biggest mistakes is using the wrong injection code for the delivery method. Another common error is failing to append the right modifier, which leads to bundling denials.
Many PE-backed groups also forget to include the drug HCPCS code alongside the administration code. Both codes are needed for full reimbursement of the treatment.
How to Build a Billing Code Reference for Your Portfolio
Creating a master billing code reference saves time and reduces errors across all your locations. This reference should list every peptide treatment offered, along with the matching CPT, HCPCS, and modifier codes.
Update the reference every quarter to keep up with code changes and new peptide products. Share it with all billing staff and providers across your portfolio.
Build a payer-specific cheat sheet mapping each peptide you administer to its CPT, HCPCS, and modifier codes, then update it quarterly as payers issue new coverage policies and peptide-specific codes emerge.
Training Your Team on Peptide Billing Codes
Your billing team needs specific training on peptide therapy codes. General medical billing knowledge is not enough for this specialized area.
Hold monthly training sessions to review denied claims and correct coding errors. Use real examples from your own claims data to make the training practical and useful.
The Role of Documentation in Code Selection
Good documentation is the foundation of correct billing. The provider's notes must clearly support the codes selected for each claim.
Every peptide therapy visit should include the diagnosis, the specific peptide used, the dose, the route of administration, and the medical necessity. Missing any of these elements can lead to a denied or reduced claim.
Auditing Your Peptide Therapy Billing Codes
Regular audits help you find and fix coding problems before they become expensive. Audit at least 10% of your peptide therapy claims each month. For additional context, the CMS HCPCS coding resources offers relevant guidance on this topic.
Look for patterns in denials that point to specific coding errors. Use audit findings to update your training materials and code reference documents.
Healthcare organizations that conduct regular billing audits recover an average of 5-10% more revenue than those that do not audit their claims.
Staying Current with Code Updates
CPT and HCPCS codes change every year. New codes are added, old codes are retired, and existing codes may get new descriptions.
Subscribe to updates from the AMA and CMS to stay informed about code changes. Assign one person on your team to track and communicate code updates across your portfolio.
Working with Payers on Peptide Therapy Codes
Not all insurance companies handle peptide therapy codes the same way. Some payers have specific rules or prior authorization requirements for certain peptide treatments.
Build relationships with your payer representatives to understand their specific requirements. Keep a payer-specific guide that notes any differences in how each insurance company handles peptide billing.
How Technology Helps with Code Accuracy
Modern billing software can suggest codes based on the documentation entered. This reduces the chance of human error in code selection.
Some platforms also flag potential coding errors before the claim is submitted. PE-backed groups should invest in technology that supports accurate peptide therapy billing.
Scaling Peptide Billing Across Multiple Locations
PE portfolios often include many locations, which makes consistent billing harder. A centralized billing team or shared service center can help keep coding consistent.
Standard operating procedures should be the same at every location. Regular cross-location audits ensure that all sites are following the same billing practices.
PE-backed healthcare groups that standardize their peptide therapy billing codes across all portfolio locations see fewer denials and faster reimbursement cycles.
PE-backed healthcare groups that standardize their peptide billing workflows around correct CPT, HCPCS, and modifier codes will reduce claim denials and unlock the full revenue potential of their peptide therapy programs.
Frequently Asked Questions
What are the most common CPT codes for peptide therapy?
The most common CPT codes include 96372 for subcutaneous or intramuscular injections and 96365-96368 for IV infusions. E/M codes 99202-99215 are also used for the office visit portion of the appointment.
Why do peptide therapy claims get denied so often?
Peptide therapy claims often get denied because of incorrect code selection, missing modifiers, or lack of medical necessity documentation. Using unclassified HCPCS codes like J3490 without proper support documentation also leads to higher denial rates.
How often should we update our billing code reference?
You should update your billing code reference at least every quarter. Annual CPT and HCPCS code updates from the AMA and CMS should be reviewed and applied as soon as they take effect.
Can we use the same billing codes across all payers?
While CPT and HCPCS codes are standardized, individual payers may have different rules about which codes they accept for peptide therapy. Always check payer-specific guidelines and maintain a reference that notes any differences.
How does PE ownership affect peptide therapy billing?
PE ownership creates a need for standardized billing across multiple locations and consistent revenue reporting. This means billing codes must be applied uniformly, and centralized oversight is essential to maintain accuracy and compliance.
Partner with PeptideStaff for Expert Billing Support
Getting peptide therapy billing codes right is essential for PE-backed healthcare groups that want to grow revenue and reduce denials. Our team at PeptideStaff specializes in placing skilled billing professionals who understand peptide therapy inside and out.
Contact PeptideStaff today to find the billing talent your portfolio needs. Let us help you build a team that gets every claim right the first time.
Topics
Jennifer Walsh
Senior Healthcare Staffing Consultant
RN, BSN | 13 years placing clinical professionals in wellness practices
Registered nurse and staffing specialist who has placed over 400 clinical professionals across peptide therapy, hormone optimization, and integrative medicine clinics. Expertise in credentialing and retention strategy.
Reviewed by Jennifer Walsh, RN, April 2026